External Validation of the Updated Partin Tables in a Cohort of French and Italian Men

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 2, 2009, Pages 347-352

  Bhojani, Naeem ^a   Salomon, Laurent ^b   Capitanio, Umberto ^a,c   Suardi, Nazareno ^a,c   Shariat, Shahrokh F ^a   Jeldres, Claudio ^a   Zini, Laurent ^a,d   Pharand, Daniel ^a   Péloquin, François ^a   Arjane, Philippe ^a   Abbou, Claude C ^b   De La Taille, Alexandre ^b   Montorsi, Francesco ^c   Karakiewicz, Pierre I ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HENRI MONDOR HOSPITAL   (France)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIV LILLE   (France)

Author keywords

Prognosis; Prostate cancer; Staging

Indexed keywords

CALIBRATION;

CALIBRATION PLOTS; CLINICAL PRACTICES; EUROPEANS; EXTERNAL-; LOCALIZED PROSTATE CANCERS; LYMPH NODES; PREDICTIVE MODELS; PROGNOSIS; PROSTATE CANCER; RADICAL PROSTATECTOMIES; RECEIVER OPERATING CHARACTERISTIC CURVE ANALYSES; SEMINAL VESICLES; STAGE PREDICTIONS; STAGING; WORSE PERFORMANCES;

FORECASTING;

ARTICLE; CALIBRATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CLINICAL EVALUATION; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FRANCE; HISTOPATHOLOGY; HUMAN; ITALY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; SEMINAL VESICLE; SENSITIVITY AND SPECIFICITY;

CALIBRATION; COHORT STUDIES; FRANCE; HUMANS; ITALY; LYMPH NODES; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PELVIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE; SEMINAL VESICLES; SENSITIVITY AND SPECIFICITY;

EID: 58149350011     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.082     Document Type: Article

References (15)

1. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110-114
2. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
3. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843-848
4. Makarov D.V., Trock B.J., Humphreys E.B., et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 69 (2007) 1095-1101
5. Blute M.L., Bergstralh E.J., Partin A.W., et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 164 (2000) 1591-1595
6. Penson D.F., Grossfeld G.D., Li Y.P., et al. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol 167 (2002) 1653-1657 discussion 1657-1658
7. Karakiewicz P.I., Lattouf J.B., Perrotte P., et al. Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec. Can J Urol 12 (2005) 2588-2592
8. Steuber T., Karakiewicz P.I., Augustin H., et al. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol 173 (2005) 737-741
9. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. Br J Urol Int 98 (2006) 788-793
10. Briganti A., Chun F.K., Salonia A., et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50 (2006) 1006-1013
11. Steuber T., Graefen M., Haese A., et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 175 (2006) 939-944 discussion 944
12. Kattan M.W. Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Eur Urol 52 (2007) 1528
13. Augustin H., Eggert T., Wenske S., et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 171 (2004) 177-181
14. Bartsch G., Horninger W., Klocker H., et al. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58 (2001) 417-424
15. Schroder F.H., Habbema D.F., Roobol M.J., et al. Prostate cancer in the Swedish section of ERSPC-evidence for less metastases at diagnosis but not for mortality reduction. Eur Urol 51 (2007) 588-590